Latest On Tenax Therapeutics, Inc (TENX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-03-08 01:11 EST | News | Tenax Therapeutics a buy at RothMKM due to late-stage pulmonary hypertension assets | N/A |  |
| 2023-02-03 13:15 EST | News | Tenax Therapeutics stock dips after pricing $15.6M securities offering | N/A | |
| 2023-02-03 00:10 EST | News | Tenax stock surges ~65% on upcoming US patent linked to heart disease therapy | N/A | |
| 2023-01-04 10:45 EST | News | Tenax Therapeutics to execute 1-for-20 reverse stock split | N/A | |
| 2022-09-15 22:59 EST | News | Tenax to evaluate strategic alternatives including a sale or a merger, shares rise ~7% | N/A | |
| 2022-05-18 14:28 EST | News | Tenax therapeutics announces $8M PIPE offering | N/A | |
| 2022-03-31 19:21 EST | News | Tenax Therapeutics GAAP EPS of -$1.58 misses by $1.51 | N/A | |
| 2022-01-12 11:35 EST | News | Tenax Therapeutics nabs new U.S. patent for the subcutaneous use of levosimendan | N/A | |
| 2021-11-17 04:36 EST | News | Tenax Therapeutics EPS misses by $0.02 | N/A | |
| 2021-10-28 03:47 EST | News | Warning: TENX is at high risk of performing badly | N/A | |
| 2021-08-13 01:23 EST | News | Tenax's highlights levosimendan mechanism in cardiovascular diseases | N/A | |
| 2021-07-22 03:26 EST | News | Tenax Therapeutics reports retirement of CEO and $10M PIPE financing | N/A | |
| 2021-04-09 11:18 EST | News | Tenax levosimendan improves hemodynamics, exercise tolerance in cardio-pulmonary diseases | N/A | |
| 2021-04-07 22:21 EST | News | Tenax Therapeutics chairman to retire | N/A | |
| 2021-04-01 04:46 EST | News | Tenax Therapeutics EPS misses by $0.49 | N/A | |
| 2021-02-15 12:29 EST | Analyst Rating | The Analyst Target Price has increased from $3.67 to $4.5. | Buy | |
| 2021-01-19 18:14 EST | News | Tenax Therapeutics acquires PH Precision Med | N/A | |
| 2020-12-30 12:50 EST | Analyst Rating | The Analyst Target Price has increased from $3 to $3.67. | Buy | |
| 2020-11-26 21:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-20 13:05 EST | Analyst Rating | The Analyst Target Price has decreased from $4.22 to $3. | Neutral | |
| 2020-11-17 21:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-17 20:57 EST | News | Tenax Therapeutics EPS misses by $0.04 | N/A | |
| 2020-11-17 12:55 EST | Earnings Estimate | An EPS average of -$0.29 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-11-14 12:39 EST | News | Acceleron's sotatercept shows positive action in mid-stage pulmonary arterial hypertension studies | N/A | |
| 2020-11-08 01:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 17:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-16 03:34 EST | News | Tenax Therapeutics gains North American rights to oral levosimendan; shares +14% | N/A | |
| 2020-09-26 14:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 06:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-09 19:28 EST | Insider Trade | ARMISTICE CAPITAL, LLC has indirectly acquired of 0 shares. | Buy | |
| 2020-09-09 19:28 EST | Insider Trade | ARMISTICE CAPITAL, LLC has directly acquired 8,543 shares and currently holds 2,019,995 shares. | Buy | |
| 2020-09-09 19:28 EST | Insider Trade | ARMISTICE CAPITAL, LLC has indirectly acquired of 0 shares. | Buy | |
| 2020-09-09 19:28 EST | Insider Trade | ARMISTICE CAPITAL, LLC has directly acquired 23,457 shares and currently holds 2,011,452 shares. | Buy | |
| 2020-09-03 18:04 EST | Insider Trade | ARMISTICE CAPITAL, LLC has directly acquired 36,000 shares and currently holds 1,987,995 shares. | Buy | |
| 2020-09-03 18:04 EST | Insider Trade | ARMISTICE CAPITAL, LLC has indirectly acquired of 0 shares. | Buy | |
| 2020-09-03 18:04 EST | Insider Trade | ARMISTICE CAPITAL, LLC has indirectly acquired of 0 shares. | Buy | |
| 2020-09-03 18:04 EST | Insider Trade | ARMISTICE CAPITAL, LLC has directly acquired 20,000 shares and currently holds 1,951,995 shares. | Buy | |
| 2020-09-03 18:04 EST | Insider Trade | ARMISTICE CAPITAL, LLC has directly acquired 30,000 shares and currently holds 1,931,995 shares. | Buy | |
| 2020-09-03 18:04 EST | Insider Trade | ARMISTICE CAPITAL, LLC has indirectly acquired of 0 shares. | Buy | |
| 2020-08-31 19:45 EST | Insider Trade | ARMISTICE CAPITAL, LLC has indirectly acquired of 0 shares. | Buy | |
| 2020-08-31 19:45 EST | Insider Trade | ARMISTICE CAPITAL, LLC has directly acquired 20,000 shares and currently holds 1,901,995 shares. | Buy | |
| 2020-08-31 19:45 EST | Insider Trade | ARMISTICE CAPITAL, LLC has indirectly acquired of 0 shares. | Buy | |
| 2020-08-31 19:45 EST | Insider Trade | ARMISTICE CAPITAL, LLC has directly acquired 12,000 shares and currently holds 1,881,995 shares. | Buy | |
| 2020-08-27 09:44 EST | Analyst Rating | The Analyst Target Price has decreased from $5.47 to $4.22. | Neutral | |
| 2020-08-26 18:15 EST | Insider Trade | ARMISTICE CAPITAL, LLC has indirectly acquired of 0 shares. | Buy | |
| 2020-08-26 18:15 EST | Insider Trade | ARMISTICE CAPITAL, LLC has directly acquired 12,000 shares and currently holds 1,869,995 shares. | Buy | |
| 2020-08-26 18:15 EST | Insider Trade | ARMISTICE CAPITAL, LLC has indirectly acquired of 0 shares. | Buy | |
| 2020-08-26 18:15 EST | Insider Trade | ARMISTICE CAPITAL, LLC has directly acquired 17,211 shares and currently holds 1,857,995 shares. | Buy | |
| 2020-08-26 18:15 EST | Insider Trade | ARMISTICE CAPITAL, LLC has indirectly acquired of 0 shares. | Buy | |
| 2020-08-26 18:15 EST | Insider Trade | ARMISTICE CAPITAL, LLC has directly acquired 5,692 shares and currently holds 1,840,784 shares. | Buy | |
About Tenax Therapeutics, Inc (TENX):
Tenax Therapeutics, Inc., a specialty pharmaceutical company, focuses on identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. The company focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing low cardiac output syndrome. It is also involved in initiating a Phase 2 clinical trial of levosimendan for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.
General
- Name Tenax Therapeutics, Inc
- Symbol TENX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 9
- Last Split Factor1:20
- Last Split Date2018-02-26
- Fiscal Year EndDecember
- IPO Date1997-01-02
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.tenaxthera.com
View More
Valuation
- Forward PE 16.21
- Price/Book (Most Recent Quarter) 4.45
- Enterprise Value EBITDA 0.07
View More
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.13
- Return on Assets -73%
- Return on Equity -141%
- Earnings Per Share -$3.95
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 31.2 million
- EBITDA -7226812
- Analyst Target Price $4.5
- Book Value Per Share $0.59
View More
Share Statistics
- Shares Outstanding 14.51 million
- Shares Float 10.25 million
- % Held by Insiders 33%
- % Held by Institutions 32.15%
- Shares Short 569417
- Shares Short Prior Month 576087
- Short Ratio 0.46
- Short % of Float 4%
- Short % of Shares Outstanding 4%
View More
Technicals
- Beta 2.35
- 52 Week High $3.68
- 52 Week Low $0.45
- 50 Day Moving Average 2.37
- 200 Day Moving Average 1.63
View More
Dividends
- Dividend Date 2018-02-26
- ExDividend Date N/A
- Dividend Yield 0%
View More
Tenax Therapeutics, Inc (TENX) Dividend Calendar:
TENX's last dividend payment was made to shareholders on February 26, 2018.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Tenax Therapeutics, Inc (TENX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-16 | $N/A | -$0.18 | -$0.15 | -24.14% |
| 2020-06-30 | 2020-08-14 | $N/A | -$0.23 | -$0.21 | -9.52% |
| 2020-03-31 | 2020-05-15 | $N/A | -$0.38 | -$0.19 | -100% |
| 2019-12-31 | 2020-03-30 | $N/A | -$0.42 | -$0.61 | 30.58% |
| 2019-09-30 | 2019-11-14 | $N/A | -$0.33 | -$0.37 | 9.59% |
| 2019-06-30 | 2019-08-14 | $N/A | -$0.28 | -$0.45 | 37.78% |
| 2019-03-31 | 2019-05-15 | $N/A | -$0.33 | -$0.34 | 2.94% |
| 2018-12-31 | 2019-03-31 | $N/A | -$5.87 | -$0.31 | -1793.87% |
| 2018-09-30 | 2018-11-14 | $N/A | -$1.05 | -$1.46 | 28.08% |
| 2018-06-30 | 2018-08-14 | $N/A | -$1.29 | -$1.45 | 10.73% |
| 2018-03-31 | 2018-05-15 | $N/A | -$0.83 | -$1.31 | 36.64% |
| 2017-12-31 | 2018-03-20 | $N/A | -$0.95 | -$1.07 | 11.05% |
| 2017-09-30 | 2017-11-09 | $N/A | -$0.80 | -$1.10 | 27.27% |
| 2017-06-30 | 2017-08-09 | $N/A | -$2.20 | -$1.80 | -22.22% |
| 2017-03-31 | 2017-05-10 | $N/A | -$2.40 | -$2.00 | -20% |
| 2016-12-31 | 2017-03-16 | $N/A | -$21.00 | -$2.80 | -650% |
| 2016-09-30 | 2016-11-09 | $N/A | -$3.00 | -$3.30 | 9.09% |
| 2016-06-30 | 2016-08-09 | $N/A | -$3.40 | -$3.40 | 0% |
| 2016-03-31 | 2016-05-10 | $N/A | -$3.80 | -$2.73 | -39.03% |
| 2015-09-30 | 2015-12-10 | $N/A | -$2.60 | -$2.70 | 3.7% |
| 2015-06-30 | 2015-07-14 | $49286 | -$2.80 | -$2.70 | -3.7% |
| 2014-12-31 | 2015-03-17 | $N/A | -$2.00 | -$3.13 | 36.1% |
| 2014-09-30 | 2014-12-15 | $N/A | -$2.80 | -$3.50 | 20% |
| 2014-06-30 | 2014-07-29 | $N/A | -$2.60 | -$7.60 | 65.79% |
| 2014-03-31 | 2014-04-02 | $104449 | -$8.74 | ||
| 2013-12-31 | 2014-03-17 | $41864 | -$8.60 | -$3.60 | -138.89% |
| 2013-09-30 | 2013-10-02 | $59000 | -$67.14 | ||
| 2013-03-31 | 2013-04-30 | $181572 | -$34.14 | ||
| 2012-12-31 | 2013-01-31 | $224000 | -$55.54 | ||
| 2012-09-30 | 2012-10-31 | $524000 | -$52.48 | ||
| 2012-06-30 | 2012-07-31 | $278000 | -$86.07 | ||
| 2012-03-31 | 2012-04-30 | $120360 | -$31.34 | ||
| 2011-12-31 | 2012-01-31 | $151000 | -$155.48 | ||
| 2011-09-30 | 2011-10-31 | $95159 | -$116.50 | ||
| 2011-06-30 | 2011-07-14 | $59000 | -$40.00 | -$40.00 | 0% |
| 2011-03-31 | 2011-04-30 | $226000 | -$48.83 | ||
| 2010-12-31 | 2011-03-21 | $53000 | -$44.00 | -$40.00 | -10% |
| 2010-09-30 | 2010-12-09 | $36000 | -$36.00 | -$52.00 | 30.77% |
| 2010-06-30 | 2010-07-23 | $7000 | -$52.00 | -$52.00 | 0% |
| 2010-03-31 | 2010-04-30 | $10000 | -$56.82 | ||
| 2009-12-31 | 2010-03-19 | $30000 | -$52.00 | -$48.00 | -8.33% |
| 2009-09-30 | 2009-12-11 | $7000 | -$52.00 | -$4.00 | -1200% |
| 2009-06-30 | 2009-07-31 | $N/A | -$58.40 | ||
| 2009-03-31 | 2009-04-30 | $N/A | -$509.99 | ||
| 2008-12-31 | 2009-01-31 | $N/A | -$308.27 | ||
| 2008-09-30 | 2008-10-31 | $N/A | -$149.32 | ||
| 2008-06-30 | 2008-07-31 | $N/A | -$169.04 | ||
| 2008-03-31 | 2008-04-30 | $N/A | -$120.00 | ||
| 2007-12-31 | 2008-01-31 | $N/A | -$98.63 | ||
| 2007-09-30 | 2007-10-31 | $N/A | -$39.79 | ||
| 2007-06-30 | 2007-07-31 | $N/A | -$43.99 | ||
| 2007-03-31 | 2007-04-30 | $N/A | -$24.00 | ||
| 2006-12-31 | 2007-01-31 | $N/A | -$38.55 | ||
| 2006-09-30 | 2006-10-31 | $N/A | -$30.27 | ||
| 2006-06-30 | 2006-07-31 | $N/A | -$31.16 | ||
| 2006-03-31 | 2006-04-30 | $N/A | -$41.92 | ||
| 2005-12-31 | 2006-01-31 | $N/A | -$44.09 | ||
| 2005-09-30 | 2005-10-31 | $N/A | -$77.31 | ||
| 2005-06-30 | 2005-07-31 | $N/A | -$29.09 | ||
| 2005-03-31 | 2005-04-30 | $N/A | -$35.89 | ||
| 2004-12-31 | 2005-01-31 | $N/A | -$44.09 | ||
| 2004-09-30 | 2004-10-31 | $N/A | -$31.23 | ||
| 2004-06-30 | 2004-07-31 | $N/A | -$24.96 | ||
| 2004-03-31 | 2004-04-30 | $N/A | -$29.99 | ||
| 2003-12-31 | 2004-01-31 | $N/A | -$49.56 | ||
| 2003-09-30 | 2003-10-31 | $N/A | -$30.86 | ||
| 2003-06-30 | 2003-07-31 | $N/A | -$30.54 | ||
| 2003-03-31 | 2003-04-30 | $N/A | -$22.67 | ||
| 2002-12-31 | 2003-01-31 | $N/A | -$31.44 | ||
| 2002-09-30 | 2002-10-31 | $N/A | -$69.56 | ||
| 2002-06-30 | 2002-07-31 | $N/A | -$27.11 | ||
| 2002-03-31 | 2002-04-30 | $N/A | -$133.63 | ||
| 2001-12-31 | 2002-01-31 | $N/A | -$32.91 | ||
| 2001-09-30 | 2001-10-31 | $N/A | -$35.74 | ||
| 2001-06-30 | 2001-07-31 | $N/A | -$36.46 | ||
| 2001-03-31 | 2001-04-30 | -$33.96 | |||
| 2000-12-31 | 2001-01-31 | -$27.86 | |||
| 2000-09-30 | 2000-10-31 | -$35.18 | |||
| 2000-06-30 | 2000-07-31 | -$18.58 |
Tenax Therapeutics, Inc (TENX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Tenax Therapeutics, Inc (TENX) Chart:
Tenax Therapeutics, Inc (TENX) News:
Below you will find a list of latest news for Tenax Therapeutics, Inc (TENX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Tenax Therapeutics, Inc (TENX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Tenax Therapeutics, Inc (TENX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495420006776/0001654954-20-006776-index.htm |
| 2018-05-22 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/34956/000000000018015768/0000000000-18-015768-index.htm |
| 2018-11-09 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/34956/000000000018035029/0000000000-18-035029-index.htm |
| 2020-09-04 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/34956/000000000020008381/0000000000-20-008381-index.htm |
| 2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/34956/000083423720008117/0000834237-20-008117-index.htm |
| 2020-08-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/34956/000083423720010111/0000834237-20-010111-index.htm |
| 2018-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/34956/000091957418001179/0000919574-18-001179-index.htm |
| 2020-03-23 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/34956/000091957420002542/0000919574-20-002542-index.htm |
| 2020-07-16 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/34956/000091957420004612/0000919574-20-004612-index.htm |
| 2020-07-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000091957420004613/0000919574-20-004613-index.htm |
| 2020-07-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000091957420004648/0000919574-20-004648-index.htm |
| 2020-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000091957420005488/0000919574-20-005488-index.htm |
| 2020-08-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000091957420005506/0000919574-20-005506-index.htm |
| 2020-08-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000091957420005631/0000919574-20-005631-index.htm |
| 2020-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000091957420005666/0000919574-20-005666-index.htm |
| 2020-09-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000091957420005750/0000919574-20-005750-index.htm |
| 2018-12-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/34956/000093041318003553/0000930413-18-003553-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/34956/000093041319000506/0000930413-19-000506-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/34956/000093041320000366/0000930413-20-000366-index.htm |
| 2019-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/34956/000103738919000081/0001037389-19-000081-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/34956/000103738920000275/0001037389-20-000275-index.htm |
| 2017-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/34956/000114420417009009/0001144204-17-009009-index.htm |
| 2017-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/34956/000114420417009129/0001144204-17-009129-index.htm |
| 2018-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/34956/000114420418008998/0001144204-18-008998-index.htm |
| 2016-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000118594516000005/0001185945-16-000005-index.htm |
| 2016-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000118594516000006/0001185945-16-000006-index.htm |
| 2016-11-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000135448816008600/0001354488-16-008600-index.htm |
| 2016-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000135448816008683/0001354488-16-008683-index.htm |
| 2016-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000135448816008686/0001354488-16-008686-index.htm |
| 2017-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000135448817000426/0001354488-17-000426-index.htm |
| 2019-02-05 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/34956/000139382519000103/0001393825-19-000103-index.htm |
| 2017-04-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000148143617000001/0001481436-17-000001-index.htm |
| 2017-07-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000148143617000002/0001481436-17-000002-index.htm |
| 2018-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000148143618000001/0001481436-18-000001-index.htm |
| 2018-04-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000148143618000002/0001481436-18-000002-index.htm |
| 2018-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000148143618000003/0001481436-18-000003-index.htm |
| 2017-01-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/34956/000153561017000010/0001535610-17-000010-index.htm |
| 2018-01-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/34956/000153561018000009/0001535610-18-000009-index.htm |
| 2016-11-29 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000165495416004381/0001654954-16-004381-index.htm |
| 2017-01-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495417000610/0001654954-17-000610-index.htm |
| 2017-03-16 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/34956/000165495417002098/0001654954-17-002098-index.htm |
| 2017-03-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495417002156/0001654954-17-002156-index.htm |
| 2017-04-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000165495417003111/0001654954-17-003111-index.htm |
| 2017-04-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495417003162/0001654954-17-003162-index.htm |
| 2017-04-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/34956/000165495417003805/0001654954-17-003805-index.htm |
| 2017-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/34956/000165495417004348/0001654954-17-004348-index.htm |
| 2017-06-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495417005605/0001654954-17-005605-index.htm |
| 2017-07-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495417006748/0001654954-17-006748-index.htm |
| 2017-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/34956/000165495417007141/0001654954-17-007141-index.htm |
| 2017-09-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495417008379/0001654954-17-008379-index.htm |
| 2017-11-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/34956/000165495417010320/0001654954-17-010320-index.htm |
| 2017-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000165495417010896/0001654954-17-010896-index.htm |
| 2017-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000165495417011773/0001654954-17-011773-index.htm |
| 2017-12-29 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/34956/000165495417011940/0001654954-17-011940-index.htm |
| 2018-01-16 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/34956/000165495418000437/0001654954-18-000437-index.htm |
| 2018-02-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495418001612/0001654954-18-001612-index.htm |
| 2018-02-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495418001818/0001654954-18-001818-index.htm |
| 2018-03-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495418002520/0001654954-18-002520-index.htm |
| 2018-04-02 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/34956/000165495418003517/0001654954-18-003517-index.htm |
| 2018-04-03 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/34956/000165495418003597/0001654954-18-003597-index.htm |
| 2018-04-20 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/34956/000165495418004203/0001654954-18-004203-index.htm |
| 2018-05-15 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/34956/000165495418005446/0001654954-18-005446-index.htm |
| 2018-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/34956/000165495418005454/0001654954-18-005454-index.htm |
| 2018-05-21 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/34956/000165495418005699/0001654954-18-005699-index.htm |
| 2018-06-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495418006310/0001654954-18-006310-index.htm |
| 2018-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495418006607/0001654954-18-006607-index.htm |
| 2018-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/34956/000165495418009137/0001654954-18-009137-index.htm |
| 2018-11-06 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/34956/000165495418012073/0001654954-18-012073-index.htm |
| 2018-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/34956/000165495418012742/0001654954-18-012742-index.htm |
| 2018-11-20 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/34956/000165495418013042/0001654954-18-013042-index.htm |
| 2018-11-20 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/34956/000165495418013051/0001654954-18-013051-index.htm |
| 2018-12-03 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/34956/000165495418013509/0001654954-18-013509-index.htm |
| 2018-12-04 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/34956/000165495418013567/0001654954-18-013567-index.htm |
| 2018-12-04 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/34956/000165495418013568/0001654954-18-013568-index.htm |
| 2018-12-06 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/34956/000165495418013611/0001654954-18-013611-index.htm |
| 2018-12-06 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/34956/000165495418013649/0001654954-18-013649-index.htm |
| 2018-12-06 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/34956/000165495418013650/0001654954-18-013650-index.htm |
| 2018-12-07 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/34956/000165495418013704/0001654954-18-013704-index.htm |
| 2018-12-07 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/34956/000165495418013705/0001654954-18-013705-index.htm |
| 2018-12-07 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/34956/000165495418013735/0001654954-18-013735-index.htm |
| 2018-12-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495418013810/0001654954-18-013810-index.htm |
| 2019-04-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/34956/000165495419003861/0001654954-19-003861-index.htm |
| 2019-04-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000165495419004580/0001654954-19-004580-index.htm |
| 2019-04-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000165495419004581/0001654954-19-004581-index.htm |
| 2019-04-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000165495419004582/0001654954-19-004582-index.htm |
| 2019-04-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000165495419004583/0001654954-19-004583-index.htm |
| 2019-04-19 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/34956/000165495419004596/0001654954-19-004596-index.htm |
| 2019-04-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000165495419004651/0001654954-19-004651-index.htm |
| 2019-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/34956/000165495419006116/0001654954-19-006116-index.htm |
| 2019-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495419007357/0001654954-19-007357-index.htm |
| 2019-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/34956/000165495419009589/0001654954-19-009589-index.htm |
| 2019-08-30 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/34956/000165495419010209/0001654954-19-010209-index.htm |
| 2019-11-08 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495419012565/0001654954-19-012565-index.htm |
| 2019-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/34956/000165495419013001/0001654954-19-013001-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495420000327/0001654954-20-000327-index.htm |
| 2020-03-13 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/34956/000165495420002580/0001654954-20-002580-index.htm |
| 2020-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495420002581/0001654954-20-002581-index.htm |
| 2020-03-27 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/34956/000165495420003352/0001654954-20-003352-index.htm |
| 2020-03-30 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/34956/000165495420003498/0001654954-20-003498-index.htm |
| 2020-04-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495420004640/0001654954-20-004640-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/34956/000165495420004643/0001654954-20-004643-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495420004979/0001654954-20-004979-index.htm |
| 2020-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/34956/000165495420005647/0001654954-20-005647-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000165495420005663/0001654954-20-005663-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000165495420005665/0001654954-20-005665-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000165495420005666/0001654954-20-005666-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000165495420005667/0001654954-20-005667-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000165495420005679/0001654954-20-005679-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000165495420005765/0001654954-20-005765-index.htm |
| 2020-06-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495420006219/0001654954-20-006219-index.htm |
| 2020-06-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495420006257/0001654954-20-006257-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/34956/000165495420006645/0001654954-20-006645-index.htm |
| 2020-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495420006776/0001654954-20-006776-index.htm |
| 2020-07-08 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/34956/000165495420007442/0001654954-20-007442-index.htm |
| 2020-07-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495420007444/0001654954-20-007444-index.htm |
| 2020-07-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495420007819/0001654954-20-007819-index.htm |
| 2020-07-22 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/34956/000165495420007918/0001654954-20-007918-index.htm |
| 2020-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/34956/000165495420009183/0001654954-20-009183-index.htm |
| 2020-08-20 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/34956/000165495420009391/0001654954-20-009391-index.htm |
| 2020-09-11 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/34956/000165495420010005/0001654954-20-010005-index.htm |
| 2020-09-11 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/34956/000165495420010006/0001654954-20-010006-index.htm |
| 2020-09-29 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/34956/000165495420010605/0001654954-20-010605-index.htm |
| 2020-10-01 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/34956/000165495420010699/0001654954-20-010699-index.htm |
| 2020-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/34956/000165495420011170/0001654954-20-011170-index.htm |
| 2020-05-18 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/34956/000178397620000008/0001783976-20-000008-index.htm |
| 2020-06-02 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/34956/000178397620000009/0001783976-20-000009-index.htm |
| 2018-05-23 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/34956/999999999518001328/9999999995-18-001328-index.htm |
| 2018-12-07 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/34956/999999999518003067/9999999995-18-003067-index.htm |
| 2020-09-30 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/34956/999999999520002631/9999999995-20-002631-index.htm |
Tenax Therapeutics, Inc (TENX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tenax Therapeutics, Inc (TENX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 33%Institutional Ownership: 3215%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-03-30 | Michael B Jebsen | CFO | Sell | 6,425.00 | 5.42 | 34,823.50 | 12,310.00 | https://www.sec.gov/Archives/edgar/data/34956/000148143618000002/0001481436-18-000002-index.htm |
| 2017-12-18 | RONALD R BLANCK | Director | Buy | 6,475.00 | 0.46 | 3,005.70 | 13,624.00 | https://www.sec.gov/Archives/edgar/data/34956/000165495417011773/0001654954-17-011773-index.htm |
| 2017-03-15 | John P Kelley | Chief Executive Officer | Buy | 213,420.00 | 1,379,931.00 | https://www.sec.gov/Archives/edgar/data/34956/000135448817000426/0001354488-17-000426-index.htm | ||
| 2016-11-22 | GERALD T PROEHL | Director | Buy | 15,433.00 | 1.59 | 24,538.47 | 15,433.00 | https://www.sec.gov/Archives/edgar/data/34956/000135448816008600/0001354488-16-008600-index.htm |
| 2020-08-19 | ARMISTICE CAPITAL, LLC | Director | Buy | 0.00 | 1,594,378.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005488/0000919574-20-005488-index.htm | ||
| 2020-08-19 | ARMISTICE CAPITAL, LLC | Director | Buy | 70,767.00 | 1.45 | 102,612.15 | 1,594,378.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005488/0000919574-20-005488-index.htm |
| 2020-08-20 | ARMISTICE CAPITAL, LLC | Director | Buy | 0.00 | 1,718,850.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005488/0000919574-20-005488-index.htm | ||
| 2020-08-20 | ARMISTICE CAPITAL, LLC | Director | Buy | 124,472.00 | 1.53 | 190,442.16 | 1,718,850.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005488/0000919574-20-005488-index.htm |
| 2020-08-21 | ARMISTICE CAPITAL, LLC | Director | Buy | 0.00 | 1,835,092.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005488/0000919574-20-005488-index.htm | ||
| 2020-08-21 | ARMISTICE CAPITAL, LLC | Director | Buy | 116,242.00 | 1.44 | 167,388.48 | 1,835,092.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005488/0000919574-20-005488-index.htm |
| 2020-08-24 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 0.00 | 1,840,784.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005506/0000919574-20-005506-index.htm | ||
| 2020-08-24 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 5,692.00 | 1.47 | 8,367.24 | 1,840,784.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005506/0000919574-20-005506-index.htm |
| 2020-08-25 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 0.00 | 1,857,995.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005506/0000919574-20-005506-index.htm | ||
| 2020-08-25 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 17,211.00 | 1.53 | 26,332.83 | 1,857,995.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005506/0000919574-20-005506-index.htm |
| 2020-08-26 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 0.00 | 1,869,995.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005506/0000919574-20-005506-index.htm | ||
| 2020-08-26 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 12,000.00 | 1.50 | 18,000.00 | 1,869,995.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005506/0000919574-20-005506-index.htm |
| 2020-08-27 | ARMISTICE CAPITAL, LLC | Director | Buy | 0.00 | 1,881,995.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005631/0000919574-20-005631-index.htm | ||
| 2020-08-27 | ARMISTICE CAPITAL, LLC | Director | Buy | 12,000.00 | 1.50 | 18,000.00 | 1,881,995.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005631/0000919574-20-005631-index.htm |
| 2020-08-31 | ARMISTICE CAPITAL, LLC | Director | Buy | 0.00 | 1,901,995.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005631/0000919574-20-005631-index.htm | ||
| 2020-08-31 | ARMISTICE CAPITAL, LLC | Director | Buy | 20,000.00 | 1.45 | 29,000.00 | 1,901,995.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005631/0000919574-20-005631-index.htm |
| 2020-09-01 | ARMISTICE CAPITAL, LLC | Director | Buy | 0.00 | 1,931,995.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005666/0000919574-20-005666-index.htm | ||
| 2020-09-01 | ARMISTICE CAPITAL, LLC | Director | Buy | 30,000.00 | 1.46 | 43,800.00 | 1,931,995.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005666/0000919574-20-005666-index.htm |
| 2020-09-02 | ARMISTICE CAPITAL, LLC | Director | Buy | 0.00 | 1,951,995.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005666/0000919574-20-005666-index.htm | ||
| 2020-09-02 | ARMISTICE CAPITAL, LLC | Director | Buy | 20,000.00 | 1.47 | 29,400.00 | 1,951,995.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005666/0000919574-20-005666-index.htm |
| 2020-09-03 | ARMISTICE CAPITAL, LLC | Director | Buy | 0.00 | 1,987,995.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005666/0000919574-20-005666-index.htm | ||
| 2020-09-03 | ARMISTICE CAPITAL, LLC | Director | Buy | 36,000.00 | 1.39 | 50,040.00 | 1,987,995.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005666/0000919574-20-005666-index.htm |
| 2017-12-18 | RONALD R BLANCK | Director | Buy | 6,475.00 | 0.45 | 2,881.38 | 20,099.00 | https://www.sec.gov/Archives/edgar/data/34956/000165495417011773/0001654954-17-011773-index.htm |
| 2020-09-04 | ARMISTICE CAPITAL, LLC | Director | Buy | 0.00 | 2,011,452.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005750/0000919574-20-005750-index.htm | ||
| 2020-09-04 | ARMISTICE CAPITAL, LLC | Director | Buy | 23,457.00 | 1.41 | 33,074.37 | 2,011,452.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005750/0000919574-20-005750-index.htm |
| 2020-09-08 | ARMISTICE CAPITAL, LLC | Director | Buy | 0.00 | 2,019,995.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005750/0000919574-20-005750-index.htm | ||
| 2020-09-08 | ARMISTICE CAPITAL, LLC | Director | Buy | 8,543.00 | 1.46 | 12,472.78 | 2,019,995.00 | https://www.sec.gov/Archives/edgar/data/34956/000091957420005750/0000919574-20-005750-index.htm |
| 2016-11-21 | James P. Mitchum | Director | Sell | 7,000.00 | 1.51 | 10,570.00 | 26,000.00 | https://www.sec.gov/Archives/edgar/data/34956/000118594516000005/0001185945-16-000005-index.htm |
| 2016-11-23 | GERALD T PROEHL | Director | Buy | 14,449.00 | 1.76 | 25,430.24 | 29,882.00 | https://www.sec.gov/Archives/edgar/data/34956/000135448816008600/0001354488-16-008600-index.htm |
| 2018-07-31 | Michael B Jebsen | CFO | Sell | 5,720.00 | 6.25 | 35,750.00 | 34,680.00 | https://www.sec.gov/Archives/edgar/data/34956/000148143618000003/0001481436-18-000003-index.htm |
| 2020-05-18 | RONALD R BLANCK | Director | Buy | 5,000.00 | 0.95 | 4,774.00 | 6,062.00 | https://www.sec.gov/Archives/edgar/data/34956/000165495420005765/0001654954-20-005765-index.htm |
| 2017-07-31 | Michael B Jebsen | CFO | Sell | 54.00 | 0.65 | 35.10 | 68,146.00 | https://www.sec.gov/Archives/edgar/data/34956/000148143617000002/0001481436-17-000002-index.htm |
| 2017-04-15 | Michael B Jebsen | CFO | Sell | 56.00 | 0.54 | 30.24 | 68,200.00 | https://www.sec.gov/Archives/edgar/data/34956/000148143617000001/0001481436-17-000001-index.htm |
| 2016-12-19 | Michael B Jebsen | CFO | Sell | 49.00 | 2.07 | 101.43 | 68,256.00 | https://www.sec.gov/Archives/edgar/data/34956/000118594516000006/0001185945-16-000006-index.htm |
| 2017-12-29 | Michael B Jebsen | CFO | Sell | 98.00 | 0.43 | 42.14 | 68,264.00 | https://www.sec.gov/Archives/edgar/data/34956/000148143618000001/0001481436-18-000001-index.htm |
| 2017-11-14 | RONALD R BLANCK | Director | Sell | 12,950.00 | 0.39 | 5,050.50 | 7,149.00 | https://www.sec.gov/Archives/edgar/data/34956/000165495417010896/0001654954-17-010896-index.htm |